Condition
Locally Advanced Cervical Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 17 Locally Advanced Cervical Cancer clinical trials that are recruiting, at sites in 21 countries (most in China (11), Mexico (3), United States (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (6), Phase 3 (2), Phase 1 (1), Phase 2/3 (1). The most active sponsors are National Institute of Cancerología (2), Chongqing University Cancer Hospital (2), Tongji Hospital (2). There are also 2 NIH-funded research projects on Locally Advanced Cervical Cancer, with $1.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 2NIH research projects
- 1New in 30 days
- 21Countries
Newest Locally Advanced Cervical Cancer clinical trials
All recruiting trials (17)
-
Iparomlimab/Tuvonralimab with nab-paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer
This trial tests whether adding Iparomlimab/Tuvonralimab to nab-paclitaxel and cisplatin before surgery can shrink locally advanced cervical cancer and safely be given to adult women.
-
Vitamin D Status and Outcomes in Locally Advanced Cervical Cancer treated with chemoradiotherapy
This study tests whether pretreatment vitamin D levels can predict how well women with locally advanced cervical cancer respond to standard chemoradiotherapy.
-
Patient-tailored 3D-printed ARCHITECT applicator for cervical cancer brachytherapy
We’re testing a 3D-printed, one-time use ARCHITECT applicator to see if it safely helps deliver brachytherapy for locally advanced cervical cancer.
-
Nanocrystalline megestrol acetate with chemoradiation for locally advanced cervical cancer
This Phase 1 trial tests whether taking nanocrystalline megestrol acetate by mouth can prevent or reduce weight and muscle loss in adults with locally advanced cervical cancer who are receiving concurrent chemoradiotherapy.
-
Cadonilimab plus cisplatin given before surgery for locally advanced cervical cancer
This study will test whether giving cadonilimab together with cisplatin before surgery helps people with resectable, locally advanced cervical cancer.
-
Pre-surgery iparomlimab and tuvonralimab with chemotherapy for locally advanced cervical cancer
This phase 2 trial tests whether giving iparomlimab and tuvonralimab with chemotherapy before surgery helps people with locally advanced cervical cancer shrink their tumors and improve outcomes.
-
Understanding cervical cancer treatment and characteristics in Italy
This study looks at how patients in Italy with advanced or recurring cervical cancer are treated and what their experiences are like.
-
Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer
This study is testing whether a new treatment combining chemoimmunotherapy and surgery can help people with locally advanced cervical cancer do better than the standard treatment of chemo and radiation.
-
Neoadjuvant immunochemotherapy for PD-L1-negative locally advanced cervical cancer
This study is testing a new treatment that combines chemotherapy with a drug called Camrelizumab to see if it can help people with PD-L1-negative locally advanced cervical cancer before surgery.
-
Comparing Cisplatin and Gemcitabine with Radiotherapy for Cervical Cancer
This study is testing whether using Cisplatin or Gemcitabine along with radiation can help people with locally advanced cervical cancer feel better and improve their outcomes.
-
Curcumin supplementation for patients with locally advanced cervical cancer
This study is testing if adding curcumin to the treatment of patients with locally advanced cervical cancer can improve their outcomes and find the safest dose to use.
-
Treatment for women with high-risk locally advanced cervical cancer
This study is testing if a new treatment called volrustomig can help women with high-risk locally advanced cervical cancer feel better after their initial treatment.
-
Combining Zimberelimab with Paclitaxel and Cisplatin for Cervical Cancer Treatment
This study is testing if a new treatment combining Zimberelimab with two chemotherapy drugs can help women with advanced cervical cancer shrink their tumors before surgery.
-
Assessing the effects of radiotherapy on tumors in cervical and pancreatic cancer
This study is testing how radiotherapy affects tumors in patients with locally advanced cervical and pancreatic cancer by collecting samples and using special imaging before, during, and after treatment.
-
Examining the link between plasma MRD and HPV DNA in advanced cervical cancer treatment outcomes
This study is testing if measuring certain markers in the blood can help predict how well treatment works for people with advanced cervical cancer.
-
Combining Cadonilimab with Radiotherapy for Advanced Cervical Cancer
This study is testing if a new treatment combining Cadonilimab with radiation therapy can help women with advanced cervical cancer who can't handle chemotherapy.
-
Comparing surgery and imaging methods for staging cervical cancer
This study is testing whether using surgery or imaging methods to stage cervical cancer helps patients live longer and feel better.
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Understanding how immunotherapy and radiation work together for cervical cancer
This project aims to find better ways to predict which patients with advanced cervical cancer will respond best to a combination of immunotherapy and chemotherapy with radiation.
Related topics
Quick answers
How many Locally Advanced Cervical Cancer clinical trials are recruiting right now?
17, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in China (11 trials), Mexico (3 trials), United States (2 trials), Italy (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 3: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.